{"DataElement":{"publicId":"7307653","version":"1","preferredName":"NCCN Risk Stratification Acute Lymphoblastic Leukemia Category","preferredDefinition":"A description of the NCCN risk stratification for acute lymphoblastic leukemia.","longName":"NCCN_RSK_STRAT_ALL_CAT","context":"DCI","contextVersion":"1","DataElementConcept":{"publicId":"7297068","version":"1","preferredName":"NCCN Risk Stratification Acute Lymphoblastic Leukemia","preferredDefinition":"An alliance of 19 leading US cancer centers, an authoritative source of information to help patients and health professionals make informed decisions about cancer care. Through the collective expertise of its member institutions, the NCCN develops, updates, and disseminates a complete library of clinical practice guidelines. These guidelines are the standard for clinical policy in oncology._The potential future harm that may arise from some present action. It is often combined or confused with the probability of an event which is seen as undesirable._The process of classifying patients into a sequence of grades or ranks as part of the randomization process or for purposes of data analysis._Leukemia with an acute onset, characterized by the presence of lymphoblasts in the bone marrow and the peripheral blood. It includes the acute B lymphoblastic leukemia and acute T lymphoblastic leukemia.","longName":"NCCN_RSK_STRAT_ALL","context":"DCI","contextVersion":"1","ObjectClass":{"publicId":"7297065","version":"1","preferredName":"National Comprehensive Cancer Network Risk Stratification","preferredDefinition":"An alliance of 19 leading US cancer centers, an authoritative source of information to help patients and health professionals make informed decisions about cancer care. Through the collective expertise of its member institutions, the NCCN develops, updates, and disseminates a complete library of clinical practice guidelines. These guidelines are the standard for clinical policy in oncology.:The potential future harm that may arise from some present action. It is often combined or confused with the probability of an event which is seen as undesirable.:The process of classifying patients into a sequence of grades or ranks as part of the randomization process or for purposes of data analysis.","longName":"C39471:C17102:C25689","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"National Comprehensive Cancer Network","conceptCode":"C39471","definition":"An alliance of 19 leading US cancer centers, an authoritative source of information to help patients and health professionals make informed decisions about cancer care. Through the collective expertise of its member institutions, the NCCN develops, updates, and disseminates a complete library of clinical practice guidelines. These guidelines are the standard for clinical policy in oncology.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Risk","conceptCode":"C17102","definition":"The potential future harm that may arise from some present action. It is often combined or confused with the probability of an event which is seen as undesirable.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Stratification","conceptCode":"C25689","definition":"The process of classifying patients into a sequence of grades or ranks as part of the randomization process or for purposes of data analysis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A68F5532-9311-7CA8-E053-4EBD850A68D4","latestVersionIndicator":"Yes","beginDate":"2020-05-26","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-05-26","modifiedBy":"ONEDATA","dateModified":"2020-05-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"7297066","version":"1","preferredName":"Acute Lymphoblastic Leukemia","preferredDefinition":"Leukemia with an acute onset, characterized by the presence of lymphoblasts in the bone marrow and the peripheral blood. It includes the acute B lymphoblastic leukemia and acute T lymphoblastic leukemia.","longName":"C3167","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Acute Lymphoblastic Leukemia","conceptCode":"C3167","definition":"Leukemia with an acute onset, characterized by the presence of lymphoblasts in the bone marrow and the peripheral blood. It includes the acute B lymphoblastic leukemia and acute T lymphoblastic leukemia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"A68F5532-931F-7CA8-E053-4EBD850A68D4","latestVersionIndicator":"Yes","beginDate":"2020-05-26","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-05-26","modifiedBy":"ONEDATA","dateModified":"2020-05-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"DCI CRF:  Duke Cancer Institute Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"A68F5532-9330-7CA8-E053-4EBD850A68D4","latestVersionIndicator":"Yes","beginDate":"2020-05-26","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-05-26","modifiedBy":"KUMMEROA","dateModified":"2020-05-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"7297101","version":"1","preferredName":"NCCN Risk Stratification ALL Category","preferredDefinition":"An alliance of 19 leading US cancer centers, an authoritative source of information to help patients and health professionals make informed decisions about cancer care. Through the collective expertise of its member institutions, the NCCN develops, updates, and disseminates a complete library of clinical practice guidelines. These guidelines are the standard for clinical policy in oncology._The potential future harm that may arise from some present action. It is often combined or confused with the probability of an event which is seen as undesirable._The process of classifying patients into a sequence of grades or ranks as part of the randomization process or for purposes of data analysis._Leukemia with an acute onset, characterized by the presence of lymphoblasts in the bone marrow and the peripheral blood. It includes the acute B lymphoblastic leukemia and acute T lymphoblastic leukemia._A grouping of items based on some commonality or by user defined characteristics.","longName":"NCCN_RSK_STRAT_ALL_CAT","context":"DCI","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"100","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Ph- ALL (Adult)","valueDescription":"NCCN Philadelphia Chromosome Negative ALL Adult Risk Group","ValueMeaning":{"publicId":"7307641","version":"1","preferredName":"NCCN Philadelphia Chromosome Negative ALL Adult Risk Group","longName":"7307641","preferredDefinition":"A subgroup of patients, aged 40 or more years, diagnosed with Philadelphia Chromosome negative ALL. (NCCN Guidelines, Version 1.2020, February 20, 2020)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"NCCN Philadelphia Chromosome Negative ALL Adult Risk Group","conceptCode":"C172165","definition":"A subgroup of patients, aged 40 or more years, diagnosed with Philadelphia Chromosome negative ALL. (NCCN Guidelines, Version 1.2020, February 20, 2020)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A69FCED4-EED7-5E8E-E053-4EBD850AA8B9","latestVersionIndicator":"Yes","beginDate":"2020-05-27","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-05-27","modifiedBy":"ONEDATA","dateModified":"2020-05-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A69FCED4-EEF0-5E8E-E053-4EBD850AA8B9","beginDate":"2020-05-27","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-05-27","modifiedBy":"ONEDATA","dateModified":"2020-05-27","deletedIndicator":"No"},{"value":"Ph- ALL (AYA)","valueDescription":"NCCN Philadelphia Chromosome Negative ALL Adolescent and Young Adult Risk Group","ValueMeaning":{"publicId":"7307642","version":"1","preferredName":"NCCN Philadelphia Chromosome Negative ALL Adolescent and Young Adult Risk Group","longName":"7307642","preferredDefinition":"A subgroup of patients, aged 15 to 39 years, diagnosed with Philadelphia Chromosome negative ALL. (NCCN Guidelines, Version 1.2020, February 20, 2020)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"NCCN Philadelphia Chromosome Negative ALL Adolescent and Young Adult Risk Group","conceptCode":"C172164","definition":"A subgroup of patients, aged 15 to 39 years, diagnosed with Philadelphia Chromosome negative ALL. (NCCN Guidelines, Version 1.2020, February 20, 2020)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A69FCED4-EEFC-5E8E-E053-4EBD850AA8B9","latestVersionIndicator":"Yes","beginDate":"2020-05-27","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-05-27","modifiedBy":"ONEDATA","dateModified":"2020-05-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A69FCED4-EF15-5E8E-E053-4EBD850AA8B9","beginDate":"2020-05-27","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-05-27","modifiedBy":"ONEDATA","dateModified":"2020-05-27","deletedIndicator":"No"},{"value":"Ph+ ALL (Adult)","valueDescription":"NCCN Philadelphia Chromosome Positive ALL Adult Risk Group","ValueMeaning":{"publicId":"7307643","version":"1","preferredName":"NCCN Philadelphia Chromosome Positive ALL Adult Risk Group","longName":"7307643","preferredDefinition":"A subgroup of patients, aged 40 or more years, diagnosed with Philadelphia Chromosome positive ALL. (NCCN Guidelines, Version 1.2020, February 20, 2020)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"NCCN Philadelphia Chromosome Positive ALL Adult Risk Group","conceptCode":"C172163","definition":"A subgroup of patients, aged 40 or more years, diagnosed with Philadelphia Chromosome positive ALL. (NCCN Guidelines, Version 1.2020, February 20, 2020)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A69FCED4-EF21-5E8E-E053-4EBD850AA8B9","latestVersionIndicator":"Yes","beginDate":"2020-05-27","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-05-27","modifiedBy":"ONEDATA","dateModified":"2020-05-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A69FCED4-EF3A-5E8E-E053-4EBD850AA8B9","beginDate":"2020-05-27","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-05-27","modifiedBy":"ONEDATA","dateModified":"2020-05-27","deletedIndicator":"No"},{"value":"Ph+ ALL (AYA)","valueDescription":"NCCN Philadelphia Chromosome Positive ALL Adolescent and Young Adult Risk Group","ValueMeaning":{"publicId":"7307644","version":"1","preferredName":"NCCN Philadelphia Chromosome Positive ALL Adolescent and Young Adult Risk Group","longName":"7307644","preferredDefinition":"A subgroup of patients, aged 15 to 39 years, diagnosed with Philadelphia chromosome positive ALL. (NCCN Guidelines, Version 1.2020, February 20, 2020)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"NCCN Philadelphia Chromosome Positive ALL Adolescent and Young Adult Risk Group","conceptCode":"C172181","definition":"A subgroup of patients, aged 15 to 39 years, diagnosed with Philadelphia chromosome positive ALL. (NCCN Guidelines, Version 1.2020, February 20, 2020)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A69FCED4-EF46-5E8E-E053-4EBD850AA8B9","latestVersionIndicator":"Yes","beginDate":"2020-05-27","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-05-27","modifiedBy":"ONEDATA","dateModified":"2020-05-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A69FCED4-EF5F-5E8E-E053-4EBD850AA8B9","beginDate":"2020-05-27","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-05-27","modifiedBy":"ONEDATA","dateModified":"2020-05-27","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008556","version":"1","preferredName":"Assessment Results","preferredDefinition":"the results of evaluations of the patient and the patient's disease.","longName":"ASSESS_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2D08DE9-38BB-7208-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"7297100","version":"1","preferredName":"National Comprehensive Cancer Network Risk Stratification Acute Lymphoblastic Leukemia Category","preferredDefinition":"An alliance of 19 leading US cancer centers, an authoritative source of information to help patients and health professionals make informed decisions about cancer care. Through the collective expertise of its member institutions, the NCCN develops, updates, and disseminates a complete library of clinical practice guidelines. These guidelines are the standard for clinical policy in oncology.:The potential future harm that may arise from some present action. It is often combined or confused with the probability of an event which is seen as undesirable.:The process of classifying patients into a sequence of grades or ranks as part of the randomization process or for purposes of data analysis.:Leukemia with an acute onset, characterized by the presence of lymphoblasts in the bone marrow and the peripheral blood. It includes the acute B lymphoblastic leukemia and acute T lymphoblastic leukemia.:A grouping of items based on some commonality or by user defined characteristics.","longName":"7297100v1.0","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"National Comprehensive Cancer Network","conceptCode":"C39471","definition":"An alliance of 19 leading US cancer centers, an authoritative source of information to help patients and health professionals make informed decisions about cancer care. Through the collective expertise of its member institutions, the NCCN develops, updates, and disseminates a complete library of clinical practice guidelines. These guidelines are the standard for clinical policy in oncology.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"Risk","conceptCode":"C17102","definition":"The potential future harm that may arise from some present action. It is often combined or confused with the probability of an event which is seen as undesirable.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Stratification","conceptCode":"C25689","definition":"The process of classifying patients into a sequence of grades or ranks as part of the randomization process or for purposes of data analysis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Acute Lymphoblastic Leukemia","conceptCode":"C3167","definition":"Leukemia with an acute onset, characterized by the presence of lymphoblasts in the bone marrow and the peripheral blood. It includes the acute B lymphoblastic leukemia and acute T lymphoblastic leukemia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Category","conceptCode":"C25372","definition":"A grouping of items based on some commonality or by user defined characteristics.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A68EDCAC-871E-5EBC-E053-4EBD850A0846","latestVersionIndicator":"Yes","beginDate":"2020-05-26","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-05-26","modifiedBy":"ONEDATA","dateModified":"2020-05-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"DCI CRF:  Duke Cancer Institute Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"A68EDCAC-872F-5EBC-E053-4EBD850A0846","latestVersionIndicator":"Yes","beginDate":"2020-05-26","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-05-26","modifiedBy":"KUMMEROA","dateModified":"2020-05-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"NCCN Risk Stratification for","type":"Preferred Question Text","description":"NCCN Risk Stratification for Acute lymphoblastic leukemia","url":null,"context":"DCI"}],"origin":"DCI CRF:  Duke Cancer Institute Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"A6A26111-9C04-71DA-E053-4EBD850A3540","latestVersionIndicator":"Yes","beginDate":"2020-05-27","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-05-27","modifiedBy":"KUMMEROA","dateModified":"2020-05-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}